Effects of high cholesterol diet on gliosis in apolipoprotein E knockout mice: Implications for Alzheimer's disease and stroke

Neuroscience Letters

Volumn 369, Issue 2, 2004, Pages 87-92

  Crisby, M ^a   Rahman, S M A ^a   Sylven C ^a   Winblad, B ^a   Schultzberg, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antioxidant; Astrocytes; DT diaphorase; Hypercholesterolemia; Immunohistochemistry; Microglia; NAD(P)H:quinone oxidoreductase

Indexed keywords

APOLIPOPROTEIN E; GLIAL FIBRILLARY ACIDIC PROTEIN;

ALZHEIMER DISEASE; ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN CELL; BRAIN CORTEX; CELL ACTIVATION; CELL LABELING; CELL STIMULATION; CHOLESTEROL DIET; CONTROLLED STUDY; GLIA CELL; GLIOSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MICROGLIA; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; STROKE; WILD TYPE;

ANIMALS; ANTIGENS, DIFFERENTIATION; APOLIPOPROTEINS E; CELL COUNT; CHOLESTEROL, DIETARY; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; NADPH DEHYDROGENASE; RISK FACTORS;

EID: 4644329094     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.05.057     Document Type: Article

References (37)

1. Bates K.A., Fonte J., Robertson T.A., Martins R.N., Harvey A.R. Chronic gliosis triggers Alzheimer's disease-like processing of amyloid precursor protein. Neuroscience. 113:2002;785-796
2. Bi X., Yong A.P., Zhou J., Ribak C.E., Lynch G. Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98:2001;8832-8837
3. del Bo R., Angeretti N., Lucca E., De Simoni M.G., Forloni G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci. Lett. 188:1995;70-74
4. Borroni B., Pettenati C., Bordonali T., Akkawi N., Di Luca M., Padovani A. Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease. Neurosci. Lett. 343:2003;213-215
5. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76:1985;1501-1513
6. Cruz K.S.S., Yazlovitskaya E., Collins J., Johnson J., DeCarli C. Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer's disease. Neurobiol. Aging. 25:2004;63-69
7. Ehehalt R., Keller P., Haass C., Thiele C., Simons K. Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts. JCB. 160:2003;113-123
8. Engelhart M.J., Geerlings M.I., Ruitenberg A., Van Sweiten J.C., Hofman A., Witteman J.C., Breteler M.M. Diet and risk of dementia:does fat matter? The Rotterdam study. Neurology. 59:2002;1915-1921
9. Ernster L., Navazio F. Soluble diaphorase in animal tissues. Acta. Chem. Scand. 12:1958;595
10. Fagan A.M., Murphy B.A., Patel S.N., Kilbridge J.F., Mobley W.C., Bu G., Holtzman D.M. Evidence for normal aging of the septo-hippocampal cholinergic system in apoE(-/-) mice but impaired clearance of axonal degeneration products following injury. Exp. Neurol. 151:1998;314-325
11. Forloni G., Demicheli F., Giorgi S., Bendotti C., Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Mol. Brain Res. 16:1992;128-134
12. K.B.J. Franklin, G. Paxinos, The Mouse Brain in Stereotaxic Coordinates, Academic Press, 1997.
13. Hartmann H., Eckert A., Muller W.E. Apoplipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity. Biochem. Biophys. Res. Commun. 200:1994;1185-1192
14. Heart Protection Study Collaborative Group, MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high risk individuals: a randomised placebo-controlled trial, Lancet 360 (2002) 7-22.
15. Igbavboa U., Hamilton J., Kim H.Y., Sun G.Y., Wood W.G. A new role for apolipoprotein E: modulating transport of polyunsaturated phospholipid molecular species in synaptic plasma membranes. J. Neurochem. 80:2002;255-261
16. Jick H., Zornberg G.L., Jick S.S., Seshadri S., Drachman D.A. Statins and risk of dementia. Lancet. 356:2000;1627-1631
17. Kivipelto M., Helkala E.L., Laakso M.P., Hanninen T., Hallikainen M., Alhaninen K., Soininen H., Tuomilehto J., Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. Br. Med. J. 322:2001;1447-1451
18. Laskowitz D.T., Matthew W.D., Bennett E.R., Schmechel D., Herbstreith M.H., Goel S., McMillian M.K. Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production. Neuroreport. 9:1998;615-618
19. Lomnitski L., Kohen R., Chen Y., Shohami E., Trembovler V., Vogel T., Michaelson D.M. Reduced levels of antioxidants in brains of apolipoprotein E-deficient mice following closed head injury. Pharmacol. Biochem. Behav. 56:1997;669-673
20. Lynch J.R., Tang W., Wang H., Vitek M.P., Bennett E.R., Sullivan P.M., Warner D.S., Laskowitz D.T. APOE genotype and an ApoE-mimetic peptide modify the systemic a central nervous system inflammatory response. J. Biol. Chem. 278:2003;48429-48433
21. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Wilson R.S., Aggarwal N., Schneider J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer's disease. Arch. Neurol. 60:2003;940-946
22. Mrak R.E., Sheng J.G., Griffin W.S. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 26:1995;816-823
23. Poirie J., Davignon J., Bouthillie D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699
24. Prasad K., Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am. Heart J. 125:1993;958-973
25. Raina A.K., Templeton D.J., Deak J.C., Perry G., Smith M.A. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. Reox. Rep. 4:1999;23-27
26. Refolo L.M., Malester B., LaFrancois J., Byrant-Thomas T., Wang R., Tint G.S., Sambamurti K., Duff K., Pappolla M.A. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in transgenic mouse models. Neurobiol. Dis. 7:2000;321-331
27. Schultzberg M., Segura-Aguilar J., Lind C. Distribution of DT diaphorase in the rat brain: biochemical and immunohistochemical studies. Neuroscience. 27:1988;763-776
28. Shea T.B., Rogers E., Ashline D., Ortiz D., Sheu M.S. Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. Free Radic. Biol. Med. 33:2002;1115-1120
29. Sheng J.G., Bora B.H., Xu G., Borchelt D.R., Price D.L., Koliatsos V.E. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis. 14:2003;133-145
30. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., Simons K. Cholesterol depletion inhibits the generation of b-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 95:1998;6460-6464
31. Sparks D.L., Hunsaker J.C., Scheffe S.W., Kryscio R.J., Henson J.L., Markesbery W.R. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol. Aging. 11:1990;601-607
32. Sparks D.L., Kuo Y.M., Roher A., Martin T., Lukas R.J. Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Ann. N.Y. Acad. Sci. 903:2000;335-343
33. Sparks D.L., Martin T.A., Gross D.R., Hunsaker J.C. III Link between heart disease, cholesterol and Alzheimer's disease: a review. Micro. Res. Tech. 50:2000;287-290
34. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.M., Salvesen G.S., Pericak-Vance M., Schmeshel D., Saunders A.M., Goldgaber D., Roses A.D. Apolipoprotien E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1977-1981
35. Walker L.C., Parker C.A., Lipinski W.J., Callahan M.J., Carroll R.T., Gandy S.E., Smith J.D., Jucker M., Bisgaier C.L. Cerebral lipid deposition in aged apolipoprotein-E-deficient mice. Am. J. Pathol. 151:1997;1371-1377
36. Wolozin B., Kellman W., Ruosseau P., Celesia G.G., Seigel G. Decreased prevalence of Alzheimer's disease associated with 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors. Arch. Neurol. 57:2000;1439-1443
37. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471